...
首页> 外文期刊>Journal of infection and public health. >Restrictive reporting of selected antimicrobial susceptibilities influences clinical prescribing
【24h】

Restrictive reporting of selected antimicrobial susceptibilities influences clinical prescribing

机译:所选抗菌药敏感性的限制性报告会影响临床处方

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Cascade and restrictive reporting are useful strategies to enhance antibiotic stewardship programs.Methods: We combined both strategies to improve the prescribing of antibiotics aimed at Gram-negative infections.Results: For Enterobacter aerogenes, the susceptibility rates to amikacin increased from 10% to 100%; for third generation cephalosporins, these rates increased from 55% to 89%. The susceptibility rates of E. aerogenes to cefepime and piperacillin-tazobactam changed little, and the ampicillin susceptibility decreased from 30% in 2009 to 11% in 2010. For Proteus mirabilis, the susceptibility rates increased for third-generation cephalosporins (48% vs. 92%) and piperacillin-tazobactam (10% vs. 98%), with minimal changes for cefepime (96% vs. 93%), ampicillin (69% vs. 73%) and amikacin (96% vs. 84%). For Pseu domonas aeruginosa, the susceptibility rates improved slightly for third-generation cephalosporins (81% vs. 91%) but reduced for piperacillin-tazobactam (99% vs. 59%). Hospital-acquired Clostridium difficile infections decreased from 0.11 to 0.07 per 1000 patient days. Conclusions: Selective reporting helps physicians choose the most appropriate antibiotics for their patients within a stewardship program, with reduced C. difficile infection.
机译:背景:级联和限制性报告是增强抗生素管理计划的有用策略。方法:我们将两种策略结合起来以改善针对革兰氏阴性菌的抗生素处方。结果:对于产气肠杆菌,对丁胺卡那霉素的敏感性从10%上升至10% 100%;对于第三代头孢菌素,这些比例从55%增加到89%。产气大肠杆菌对头孢吡肟和哌拉西林-他唑巴坦的敏感性变化不大,氨苄西林的敏感性从2009年的30%下降至2010年的11%。对于奇异变形杆菌,第三代头孢菌素的敏感性增加(48%vs. 92%)和哌拉西林-他唑巴坦(10%比98%),头孢吡肟(96%比93%),氨苄青霉素(69%比73%)和丁胺卡那霉素(96%比84%)的变化最小。对于铜绿假单胞菌,第三代头孢菌素的药敏率略有改善(81%比91%),而哌拉西林-他唑巴坦的敏感性降低(99%比59%)。医院获得的艰难梭菌感染率从每1000个患者日0.11降至0.07。结论:选择性报告可帮助医生在管理计划内为患者选择最合适的抗生素,从而减少艰难梭菌感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号